Journal of Antimicrobial Chemotherapy (2001) 48, 43-57
© 2001 The British Society for Antimicrobial Chemotherapy
Supplement |
BSAC standardized disc susceptibility testing method
1 Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK
Abstract
For nearly a decade microbiologists have used the MIC breakpoints published in the BSAC Guide to Susceptibility Testing to interpret susceptibility. Historically, and unlike the rest of Europe, the UK and Ireland have used a comparative method of disc testing to interpret susceptibility rather than one based on a correlation between MIC and zone of inhibition. Although innovative when introduced in the 1970s, Stokes' comparative method has evolved ad hoc and it has become increasingly apparent that there is a need for a standardized method of disc testing that is correlated with BSAC MIC breakpoints. The method described here, like all other standardized methods of disc testing, cannot be adapted by the user, and interpretative criteria are only applicable if the method is adhered to fully. A major advantage of this approach to susceptibility testing is that data from several sources can be combined for surveillance of resistance, a task that has been made much easier by the introduction of this method and coincides with the availability of automated zone measuring devices. It is hoped that the method described here will provide the core document for standard operating procedures; however, changes will necessarily occur over time as the method is developed and refined.
Notes
* Tel: +44-121-507-5693; Fax: +44-121-551-7763; E-mail: Jenny.Andrews{at}cityhospbham.wmids.nhs.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. B. Kaye, T. Neal, S. Nicholson, J. Szkurlat, S. Bamber, A. C. Baddon, S. Anderson, K. Seddon, N. Dwyer, A. M. Lovering, et al. Concentration and Bioavailability of Ciprofloxacin and Teicoplanin in the Cornea Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3176 - 3184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, P. Keelan, P. M. Bennett, and V. I. Enne Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli J. Antimicrob. Chemother., March 1, 2009; 63(3): 423 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Harris, P. Turner, E. A. Green, and J. C. Hartley Duplex Real-Time PCR Assay for Detection of Streptococcus pneumoniae in Clinical Samples and Determination of Penicillin Susceptibility J. Clin. Microbiol., August 1, 2008; 46(8): 2751 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rodriguez Guardado, A. Blanco, V. Asensi, F. Perez, J. C. Rial, V. Pintado, E. Bustillo, M. Lantero, E. Tenza, M. Alvarez, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments J. Antimicrob. Chemother., April 1, 2008; 61(4): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Casey, T. Worthington, P. A. Lambert, and T. S. J. Elliott Evaluation of routine microbiological techniques for establishing the diagnosis of catheter-related bloodstream infection caused by coagulase-negative staphylococci J. Med. Microbiol., February 1, 2007; 56(2): 172 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sykes, M. Appleby, J. Perry, and K. Gould An investigation of the microbiological contamination of ultrasound equipment Journal of Infection Prevention, August 1, 2006; 7(4): 16 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Denis, A. Deplano, C. Nonhoff, M. Hallin, R. De Ryck, R. Vanhoof, R. De Mendonca, and M. J. Struelens In Vitro Activities of Ceftobiprole, Tigecycline, Daptomycin, and 19 Other Antimicrobials against Methicillin-Resistant Staphylococcus aureus Strains from a National Survey of Belgian Hospitals. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2680 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Masco, K. Van Hoorde, E. De Brandt, J. Swings, and G. Huys Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products J. Antimicrob. Chemother., July 1, 2006; 58(1): 85 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fowler and A. Mackay Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user J. Med. Microbiol., January 1, 2006; 55(1): 123 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Loeffler, A. K. Boag, J. Sung, J. A. Lindsay, L. Guardabassi, A. Dalsgaard, H. Smith, K. B. Stevens, and D. H. Lloyd Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK J. Antimicrob. Chemother., October 1, 2005; 56(4): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. I. Enne, A. A. Delsol, G. R. Davis, S. L. Hayward, J. M. Roe, and P. M. Bennett Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element J. Antimicrob. Chemother., September 1, 2005; 56(3): 544 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Kerr Antibiotic treatment and susceptibility testing J. Clin. Pathol., August 1, 2005; 58(8): 786 - 787. [Full Text] [PDF]
|
|
|
|
|
|
J. F. Turton, M. E. Kaufmann, J. Glover, J. M. Coelho, M. Warner, R. Pike, and T. L. Pitt Detection and Typing of Integrons in Epidemic Strains of Acinetobacter baumannii Found in the United Kingdom J. Clin. Microbiol., July 1, 2005; 43(7): 3074 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. McGregor and B. G. Spratt Identity and Prevalence of Multilocus Sequence Typing-Defined Clones of Group A Streptococci within a Hospital Setting J. Clin. Microbiol., April 1, 2005; 43(4): 1963 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Tristram, B. Bozdogan, and P. C. Appelbaum Disc diffusion-based screening tests for extended-spectrum {beta}-lactamases in Haemophilus influenzae J. Antimicrob. Chemother., April 1, 2005; 55(4): 570 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Birtles, N. Virgincar, C. L Sheppard, R. A Walker, A. P Johnson, M. Warner, V. Edwards-Jones, and R. C George Antimicrobial resistance of invasive Streptococcus pneumoniae isolates in a British district general hospital: the international connection J. Med. Microbiol., December 1, 2004; 53(12): 1241 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Denis, A. Deplano, C. Nonhoff, R. De Ryck, R. de Mendonca, S. Rottiers, R. Vanhoof, and M. J. Struelens National Surveillance of Methicillin-Resistant Staphylococcus aureus in Belgian Hospitals Indicates Rapid Diversification of Epidemic Clones Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3625 - 3629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seaman, M. Day, A. D. Russell, and D. Ochs Susceptibility of capsular Staphylococcus aureus strains to some antibiotics, triclosan and cationic biocides J. Antimicrob. Chemother., September 1, 2004; 54(3): 696 - 698. [Full Text] [PDF]
|
|
|
|
|
|
C. J. Munday, G. M. Whitehead, N. J. Todd, M. Campbell, and P. M. Hawkey Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum {beta}-lactamases in York, UK J. Antimicrob. Chemother., September 1, 2004; 54(3): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ready, H. Lancaster, F. Qureshi, R. Bedi, P. Mullany, and M. Wilson Effect of Amoxicillin Use on Oral Microbiota in Young Children Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2883 - 2887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. El-Zimaity, A. M. Kearns, S. J. Dawson, S. Price, and G. A. J. Harrison Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area J. Antimicrob. Chemother., August 1, 2004; 54(2): 441 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Corkill, J. J. Anson, P. Griffiths, and C. Anthony Hart Detection of elements of the staphylococcal cassette chromosome (SCC) in a methicillin-susceptible (mecA gene negative) homologue of a fucidin-resistant MRSA J. Antimicrob. Chemother., July 1, 2004; 54(1): 229 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. R. Darley and A. P. MacGowan Antibiotic treatment of Gram-positive bone and joint infections J. Antimicrob. Chemother., June 1, 2004; 53(6): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Shannon and G. L. French Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000 J. Antimicrob. Chemother., May 1, 2004; 53(5): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. C. Potz, S. Mushtaq, A. P. Johnson, C. J. Henwood, R. A. Walker, E. Varey, M. Warner, D. James, and D. M. Livermore Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method J. Antimicrob. Chemother., May 1, 2004; 53(5): 729 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ze-Ze, R. Tenreiro, A. Duarte, M. J. Salgado, J. Melo-Cristino, L. Lito, M. M. Carmo, S. Felisberto, and G. Carmo Case of aortic endocarditis caused by Lactobacillus casei J. Med. Microbiol., May 1, 2004; 53(5): 451 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Johnson, C. L. Sheppard, S. J. Harnett, A. Birtles, T. Harrison, N. P. Brenwald, M. J. Gill, R. A. Walker, D. M. Livermore, and R. C. George Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England J. Antimicrob. Chemother., December 1, 2003; 52(6): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Woodford, R. Reynolds, J. Turton, F. Scott, A. Sinclair, A. Williams, and D. Livermore Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and Ireland J. Antimicrob. Chemother., October 1, 2003; 52(4): 711 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Spence and K. J. Towner Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii J. Antimicrob. Chemother., October 1, 2003; 52(4): 687 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Andrews, J. P. Ashby, G. Jevons, and R. Wise In vitro susceptibility of ertapenem by BSAC standardized methodology J. Antimicrob. Chemother., October 1, 2003; 52(4): 733 - 734. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Andrews, J. P. Ashby, G. Jevons, and R. Wise Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology J. Antimicrob. Chemother., September 1, 2003; 52(3): 526 - 527. [Full Text] [PDF]
|
|
|
|
|
|
J D Perry, L A Butterworth, A Nicholson, M R Appleby, and K E Orr Evaluation of a new chromogenic medium, Uriselect 4, for the isolation and identification of urinary tract pathogens J. Clin. Pathol., July 1, 2003; 56(7): 528 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Brenwald, J. M. Andrews, G. Jevons, and R. Wise Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology J. Antimicrob. Chemother., May 1, 2003; 51(5): 1311 - 1312. [Full Text] [PDF]
|
|
|
|
|
|
J. Barry, A. Brown, V. Ensor, U. Lakhani, D. Petts, C. Warren, and T. Winstanley Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals J. Antimicrob. Chemother., May 1, 2003; 51(5): 1191 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Marshall, R. Andruszkiewicz, S. Gupta, S. Milewski, and J. W. Payne Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues J. Antimicrob. Chemother., April 1, 2003; 51(4): 821 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Upton, S. Lang, and H. Heffernan Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance J. Antimicrob. Chemother., March 1, 2003; 51(3): 613 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Y. Tan, C. McNulty, A. Charlett, N. Nessa, C. Kelly, and T. Beswick Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice J. Antimicrob. Chemother., February 1, 2003; 51(2): 379 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Darville and A. M. Lovering Variation in the content of ciprofloxacin susceptibility testing discs: its effect on the BSAC disc method J. Antimicrob. Chemother., February 1, 2003; 51(2): 465 - 467. [Full Text] [PDF]
|
|
|
|
|
|
P. Wilson, J. A. Andrews, R. Charlesworth, R. Walesby, M. Singer, D. J. Farrell, and M. Robbins Linezolid resistance in clinical isolates of Staphylococcus aureus J. Antimicrob. Chemother., January 1, 2003; 51(1): 186 - 188. [Full Text] [PDF]
|
|
|
|
|
|
N. P. Brenwald, G. Jevons, J. M. Andrews, J.-H. Xiong, P. M. Hawkey, and R. Wise An outbreak of a CTX-M-type {beta}-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., January 1, 2003; 51(1): 195 - 196. [Full Text] [PDF]
|
|
|
|
|
|
K. P. Shannon and G. L. French Validation of the NCCLS proposal to use results only from the first isolate of a species per patient in the calculation of susceptibility frequencies J. Antimicrob. Chemother., December 1, 2002; 50(6): 965 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Manuel, A. Tuck, A. Lowes, and A. Pallett Detection of teicoplanin resistance in UK EMRSA-17 strains J. Antimicrob. Chemother., December 1, 2002; 50(6): 1089 - 1090. [Full Text] [PDF]
|
|
|
|
|
|
R. P. SPENCE, K. J. TOWNER, C. J. HENWOOD, D. JAMES, N. WOODFORD, and D. M. LIVERMORE Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK J. Med. Microbiol., December 1, 2002; 51(12): 1107 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Andrews, R. Walker, A. King, and for the BSAC Working Party on Sensitivity Testing Evaluation of media available for testing the susceptibility of Pseudomonasaeruginosa by BSAC methodology J. Antimicrob. Chemother., October 1, 2002; 50(4): 479 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. T. Sandoe, I. R. Witherden, H.-K. C. Au-Yeung, P. Kite, K. G. Kerr, and M. H. Wilcox Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases J. Antimicrob. Chemother., October 1, 2002; 50(4): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Aucken, M. Ganner, S. Murchan, B. D. Cookson, and A. P. Johnson A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics J. Antimicrob. Chemother., August 1, 2002; 50(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Brown, R. Wise, O. Sule, N. Brown, D. F J Brown, N. Burrows, V. C Weston, T. C J Boswell, R. G Finch, W. Perkins, et al. Fusidic acid cream for impetigo BMJ, June 8, 2002; 324(7350): 1394 - 1394. [Full Text]
|
|
|
|
|
|
C. J. Henwood, T. Gatward, M. Warner, D. James, M. W. Stockdale, R. P. Spence, K. J. Towner, D. M. Livermore, and N. Woodford Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J. Antimicrob. Chemother., March 1, 2002; 49(3): 479 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Landrygan, P. A. James, D. Brooks, and E. M. Kubiak Reproducibility of control organism zone diameters for batches of IsoSensitest agar manufactured from 1996 to 2000 using the BSAC disc susceptibility test method J. Antimicrob. Chemother., February 1, 2002; 49(2): 391 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lewis Antimicrobial resistance surveillance: methods will depend on objectives J. Antimicrob. Chemother., January 1, 2002; 49(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Braid and M. C. J. Wale The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in conditions simulating domestic use J. Antimicrob. Chemother., January 1, 2002; 49(1): 87 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J C Graham and A Galloway ACP Best Practice No 167: The laboratory diagnosis of urinary tract infection J. Clin. Pathol., December 1, 2001; 54(12): 911 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. King and I. Phillips The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates J. Antimicrob. Chemother., August 1, 2001; 48(2): 219 - 223. [Abstract] [Full Text] [PDF]
|
|